Many in extra vulnerable patient cohorts, like those with heart disease and diabetes, don't realize they're at elevated risk of experiencing severe disease. What can doctors and pharmacists do to help?
Beta Therapeutics isn't the first in the province to go this route. A family physician at another clinic, Perpetual Health Centre, is charging new patients $125 a month starting Nov. 1.
With an ongoing phase 3 study, pralsetinib seems to be a promising candidate for the treatment of different types of cancer because of the presence of oncogenic rearranged during transfection) fusions.